ArticleJournal of clinical gastroenterology2017
Complementary and Alternative Medicine Use in United States Adults With Liver Disease.
Article in Journal of clinical gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 40 citations in OpenAlex.
- Patterns of dietary supplement use among United States patients with steatotic liver disease: Vitamins, minerals and botanicals.World journal of hepatology · 2025Article
- Use of complementary and alternative medicine in patients with chronic liver diseases in Germany- a multicentric observational study.BMC complementary medicine and therapies · 2024Observational
- Herbal and Non-Herbal Dietary Supplements for Psychiatric Indications: Considerations in Liver Transplantation.Current psychiatry reports · 2024Review
- Complementary and alternative medicines and liver disease.Hepatology communications · 2024Review
- Prevalence of Healthcare Barriers Among US Adults With Chronic Liver Disease Compared to Other Chronic Diseases.Gastro hep advances · 2024Article
- Differences in the Perception of Dietary Supplements between Dietary Supplement/Medicine Users and Non-Users.Nutrients · 2022Article
- Physician Office Visits That Included Complementary Health Approaches in U.S. Adults: 2005-2015.Journal of integrative and complementary medicine · 2022Review
- Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.Digestive diseases and sciences · 2022Article
- Effect of betulinic acid administration on TLR-9/NF-κB /IL-18 levels in experimental liver injuryTurkish journal of medical sciences · 2021Article
- Roles ofOxidative medicine and cellular longevity · 2021Article
- Use of Complementary Alternative Medicine and the Associated Factors among Patients with Depression.Evidence-based complementary and alternative medicine : eCAM · 2021Article
- Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis.Digestive diseases and sciences · 2020Article
- Outcomes and Toxicology of Herbal Drugs in Alcoholic Hepatitis - A Single Center Experience from India.Journal of clinical and translational hepatology · 2019Article
- Review
- Factors Related to Disclosure and Nondisclosure of Dietary Supplements in Primary Care, Integrative Medicine, and Naturopathic Medicine.Journal of family medicine and disease prevention · 2019Article
- The Complementary Health Approaches for Pain Survey (CHAPS): Validity testing and characteristics of a rural population with pain.PloS one · 2018Article
- Therapeutic applications and characteristics ofAvicenna journal of phytomedicineReview
- Drug-Induced Liver Injury Associated with Complementary and Alternative Medicines.Case reports in gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
goalsTo describe the complementary and alternative medicine (CAM) use in US adults with liver disease.
backgroundThe prevalence and patterns of CAM use among US adults with liver disease have not been well characterized. The 2012 National Health Interview Survey is considered the most current and comprehensive source of information on CAM use in US adults. STUDY: Using the results of the 2012 National Health Interview Survey, the prevalence of CAM use, most common modalities used, reasons for CAM use, perceived benefits, perceived helpfulness and importance, and disclosure of CAM to health care providers were compared between adults with and without liver disease.
resultsOf the 647 adults with liver disease, 41% reported using CAM in the prior year, compared with 33% of adults without liver disease. The most common modality was herbs and supplements (23%), and 3% of respondents reported consumption of a potentially hepatotoxic substance in the previous 30 days. Only a small proportion of CAM therapies were used specifically for liver disease, with milk thistle being the most common. Among respondents with liver disease, CAM was used more commonly for anxiety or depression, fatigue, and substance use. The majority believed that these therapies improved health. Nearly one-third of therapies were not reported to health care providers, mostly due to failure of the provider to ask.
conclusionsCAM use, particularly herbs and supplements, is prevalent among US adults with liver disease. Many do not disclose their CAM use to their providers, despite some using potentially hepatotoxic substances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.